ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0769

Impact of Non-Pharmacological Interventions in Indigenous Populations with Diabetes Mellitus on Cardiovascular and Kidney Disease: A Scoping Review Using the REAIM Framework

Session Information

Category: Diabetic Kidney Disease

  • 602 Diabetic Kidney Disease: Clinical

Authors

  • Okpechi, Ikechi G., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Muneer, Shezel, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Tinwala, Mohammed M., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Ghimire, Anukul, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Khan, Maryam, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Sultana, Naima, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Ye, Feng, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Zaidi, Deenaz, University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
  • Bello, Aminu K., University of Alberta Faculty of Medicine & Dentistry, Edmonton, Alberta, Canada
Background

Diabetes mellitus is a common cause of mortality from cardiovascular (CV) and kidney diseases. This scoping review utilized the RE-AIM (reach, efficacy, adoption, implementation, and maintenance) framework to assess the impact of non-pharmacological interventions on CV and kidney health outcomes (KHO) in Indigenous populations

Methods

We searched Medline, Embase, Cochrane Library, CINAHL, Web of Science, PsycINFO and other grey literature to identify studies that used non-pharmacological interventions (exercise, nutrition, telehealth, educational, health worker, and cultural) to achieve improved glycaemic control, and reduction of clinical or laboratory markers of CV or KHO in Indigenous communities

Results

Our search yielded 7,692 studies, from which 35 studies were selected. Culturally appropriate interventions were mostly utilized (77.1%); telehealth programs were least utilized (8.6%). Clinical and laboratory indices of CV and KHO were infrequently assessed (KHO assessed in 40%); improved kidney function was reported in 10.5% of health worker interventions. (Table 1). Reporting of items of the RE-AIM framework showed that internal validity items were more frequently reported than those of external validity: reach (60%), efficacy (52.1%), adoption (46.1%), implementation (41.9%), and maintenance (37.2%) (Table 2)

Conclusion

Due to the high prevalence of CV and kidney diseases in diabetic patients of Indigenous groups, studies using diabetes interventions need to report more items of external validity to allow the findings of such interventions to be translatable into practice

Table 1

Table 2